Cargando…
Testing for Human Immunodeficiency Virus Among Cancer Survivors Under Age 65 in the United States
INTRODUCTION: Knowing the human immunodeficiency virus (HIV) serostatus of patients at the time of cancer diagnosis or cancer recurrence is prerequisite to coordinating HIV and cancer treatments and improving treatment outcomes. However, there are no published data about HIV testing among cancer sur...
Autores principales: | Li, Jun, Thompson, Trevor D., Tai, Eric, Zhao, Guixiang, Oster, Alexandra M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232332/ https://www.ncbi.nlm.nih.gov/pubmed/25393748 http://dx.doi.org/10.5888/pcd11.140274 |
Ejemplares similares
-
Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States
por: Dailey, Andre F., et al.
Publicado: (2017) -
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
por: Bull-Otterson, Lara, et al.
Publicado: (2022) -
State-Specific Healthy Life Expectancy at Age 65 Years — United States, 2007–2009
por: Chang, Man-Huei, et al.
Publicado: (2013) -
Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions
por: Shahangian, Shahram, et al.
Publicado: (2021) -
Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States
por: Li, Jun, et al.
Publicado: (2016)